AC
WST icon

Armistice Capital’s West Pharmaceutical WST Stock Holding History

Armistice Capital’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$208K Buy
+578
New +$177K ﹤0.01% 291
2024
Q3 		– Sell
-13,283
Closed -$4.38M – 324
2024
Q2 		$4.38M Sell
13,283
-2,694
-17% -$952K 0.06% 118
2024
Q1 		$6.32M Buy
+15,977
New +$5.91M 0.08% 115

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Armistice Capital's WST Position: Q2 2026 in Review

Armistice Capital opened a new position in West Pharmaceutical (WST) in Q2 2026: 578 shares worth $208K. The stake represents ﹤0.01% of the portfolio and ranks #291 among its holdings. This is a return to the name: Armistice Capital previously reported a position in WST as recently as Q2 2024.

Armistice Capital first reported a position in WST in Q1 2024 and has held it in 3 quarters since. The position peaked at $6.32M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Armistice Capital held 578 shares of West Pharmaceutical worth $208K as of Q2 2026.
  • West Pharmaceutical was a new Armistice Capital position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Armistice Capital's portfolio in Q2 2026, its #291 holding.
  • Armistice Capital first reported a position in West Pharmaceutical in Q1 2024 and has held it in 3 quarters since.
  • Armistice Capital's West Pharmaceutical position peaked at $6.32M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.